GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sharda Cropchem SHARDACROP.NS · INR

Materials · NSE · 🇮🇳 India

Compare

690.50

+0.71%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Sharda Cropchem

Its shares trade on NSE under the ticker SHARDACROP.NS. It has been listed since 23 September 2014. In the fiscal year to 31 March 2026, it reported revenue of ₹52.68bn and net income of ₹6.81bn. At that date it held total assets of ₹57.80bn and shareholders' equity of ₹31.36bn.

Sharda Cropchem Ltd. is a holding company, which engages in the marketing and distribution of formulations and generic active ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2014-09-23. The firm is focused on agrochemicals and non-agrichemical businesses. The firm operates through an asset-light business model, and its core competency lies in developing product dossiers and obtaining product registrations in different countries. The firm operates through two segments: Agrochemicals and Non-agrochemicals. Agrochemicals segment is engaged in Insecticides, Herbicides, Fungicides and Biocides. Non-agrochemicals segment is engaged in Conveyor Belts, V Belts and Timing Belts. Its product portfolio in the agrochemical business comprises formulations and generic active ingredients in fungicide, herbicide and insecticide segments for protecting different kinds of crops, as well as serving turf and specialty markets and a range of formulations and generic active ingredients. The product portfolio in the non-agrochemical business comprises belts, general chemicals, dyes and dye intermediates.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Materials
Industry
Chemicals
Listed since
23 Sept 2014
Employees
182

Leadership

Pay as last reported

  • Mr. Ramprakash BubnaExecutive Chairman of the Board, Managing Director, Founder, since 2004₹43.6m
  • Mr. Shailesh MehendaleChief Financial Officer
  • Mr. Jetkin GudhkaChief Compliance Officer, Company Secretary₹2.1m
  • Mr. Ashish BubnaWhole-time Director, Founder, since 2004₹32.9m
  • Mr. Manish BubnaWhole-Time Director, Founder, since 2004₹32.9m
  • Mrs. Sharda BubnaWhole-time Director, Founder, since 2004₹3.8m
  • Ms. Sonal DesaiNon-Executive Independent Director₹585,000
  • Mr. Shalin DivatiaNon-Executive Independent Director₹135,000
  • Mr. H. S. Upendra KamathNon-Executive Independent Director₹315,000
  • Mr. Vinod KathuriaNon-Executive Independent Director₹270,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
37
Environment
26
Social
36
Governance
48
Women in the workforce
54.3%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Holding company with marketing and distribution focus in formulations and generic active ingredients.
  • Operates through an asset-light business model with core competency in product dossiers and registrations.
  • Two business segments: Agrochemicals and Non-agrochemicals with diverse product portfolios.

Weaknesses

  • No specific weaknesses mentioned in the provided information.
  • No details on financial performance or market share provided.
  • Limited information on competitive advantages beyond asset-light model.

Opportunities

  • Expansion in agrochemicals and non-agrochemicals segments through existing product portfolios.
  • Potential growth in global markets due to focus on product registrations in different countries.
  • Asset-light model allows for scalability without significant capital investment.

Threats

  • No specific threats mentioned in the provided information.
  • Dependence on regulatory approvals for product registrations.
  • Competition in agrochemical and non-agrochemical markets without detailed market analysis.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.